InvestorsHub Logo

KoKid3g1

07/08/14 6:29 PM

#115343 RE: conix #115338

Sure, if they can get past phase one LOL!

http://www.signaturerx.com/view.cfm/6/Pipeline

Couch

07/08/14 6:43 PM

#115345 RE: conix #115338

IMO Great company- great technology- but the company is private and Elite is ahead of them in terms of getting their drugs to market. Still waiting - you want me to repost that 8k yet again?

lasers

07/08/14 7:02 PM

#115347 RE: conix #115338

Street junkies charcoal the organics to get the refractory opioids. Signature Therapeutics opioids will fail like all the other ART physical barriers.

$ELTP ADT ELI200/ELI201/ELI202/ELI216 work because both agonist and antagonist are refractory opioids. Charcoaling does no good whatsoever!

Signature Therapeutics opioids are NO competition whatsoever to $ELTP family of ADTs.

elichen

07/08/14 8:06 PM

#115348 RE: conix #115338

Administered intravenously--huge added expense, unpleasant experience and extremely inconvenient for ongoing use.

Steges

07/08/14 8:38 PM

#115353 RE: conix #115338

Lynn Webster is a scientific advisor which is interesting to say the least. Wether that is good or bad is to be determined. That said, they are years behind where Elite is right now so for now, no.

Hike

07/08/14 9:13 PM

#115356 RE: conix #115338

"our prodrugs"??

I'm supposed to take this seriously?

Minding

07/09/14 10:26 AM

#115385 RE: conix #115338

A reasonable question, conix. It's worthwhile getting to know the competition; more difficult with private companies to verify what they're doing ... which also means people here who say they know may or may not know -- source links/material are critical to support facts.

Minding